These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 26356527)

  • 1. [Oxidative stress and Parkinson's disease: mechanisms and perspectives of treatment].
    Katunina EA; Titova NV; Malykhina EA; Gasanov MG; Makarova AA; Voronina TA; Nerobkova LN; Valdman EA; Avakyan GN
    Zh Nevrol Psikhiatr Im S S Korsakova; 2015; 115(7):141-145. PubMed ID: 26356527
    [No Abstract]   [Full Text] [Related]  

  • 2. The current state of free radicals in Parkinson's disease. Nigral iron as a trigger of oxidative stress.
    Friedman A; Galazka-Friedman J
    Adv Neurol; 2001; 86():137-42. PubMed ID: 11553971
    [No Abstract]   [Full Text] [Related]  

  • 3. Pesticides and metals induced Parkinson's disease: involvement of free radicals and oxidative stress.
    Singh C; Ahmad I; Kumar A
    Cell Mol Biol (Noisy-le-grand); 2007 May; 53(5):19-28. PubMed ID: 17543230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calcium homeostasis, free radical formation, and trophic factor dependence mechanisms in Parkinson's disease.
    De Erausquin GA; Costa E; Hanbauer I
    Pharmacol Rev; 1994 Dec; 46(4):467-82. PubMed ID: 7899474
    [No Abstract]   [Full Text] [Related]  

  • 5. [Free radicals and ailing proteins--the culprits behind Parkinson disease?].
    Smith R; Lotharius J; Brundin P
    Lakartidningen; 2003 Apr; 100(15):1324-6, 1329-30. PubMed ID: 12739402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Free radical damage and oxidative stress in Huntington's disease.
    Borlongan CV; Kanning K; Poulos SG; Freeman TB; Cahill DW; Sanberg PR
    J Fla Med Assoc; 1996 May; 83(5):335-41. PubMed ID: 8666972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Free radicals in Parkinson's disease.
    Koutsilieri E; Scheller C; Grünblatt E; Nara K; Li J; Riederer P
    J Neurol; 2002 Sep; 249 Suppl 2():II1-5. PubMed ID: 12375056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Etiology and pathogenesis of parkinson's disease].
    Mizuno Y; Ikebe S; Mochizuki H; Matumine H; Kondo T
    No To Shinkei; 1996 Jan; 48(1):5-17. PubMed ID: 8679319
    [No Abstract]   [Full Text] [Related]  

  • 9. [Fat-soluble vitamin therapy in senile dementia and Parkinson's disease].
    Nakashima K; Takahashi K
    Nihon Rinsho; 1993 Apr; 51(4):1017-22. PubMed ID: 8483257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxidative stress in Parkinson's disease and other neurodegenerative disorders.
    Jenner P
    Pathol Biol (Paris); 1996 Jan; 44(1):57-64. PubMed ID: 8734302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. No evidence for systemic oxidant stress in Parkinson's or Alzheimer's disease.
    Ahlskog JE; Uitti RJ; Low PA; Tyce GM; Nickander KK; Petersen RC; Kokmen E
    Mov Disord; 1995 Sep; 10(5):566-73. PubMed ID: 8552107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antioxidants as therapy for Parkinson's disease.
    Shults CW
    Antioxid Redox Signal; 2005; 7(5-6):694-700. PubMed ID: 15890014
    [No Abstract]   [Full Text] [Related]  

  • 13. Nitrite and malondialdehyde content in cerebrospinal fluid of patients with Parkinson's disease.
    Shukla R; Rajani M; Srivastava N; Barthwal MK; Dikshit M
    Int J Neurosci; 2006 Dec; 116(12):1391-402. PubMed ID: 17145675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The oxidant stress hypothesis in Parkinson's disease: evidence supporting it.
    Fahn S; Cohen G
    Ann Neurol; 1992 Dec; 32(6):804-12. PubMed ID: 1471873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metal ions and oxidative protein modification in neurological disease.
    Sayre LM; Moreira PI; Smith MA; Perry G
    Ann Ist Super Sanita; 2005; 41(2):143-64. PubMed ID: 16244388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Free radicals, oxidative stress and the origin of Parkinson's disease.
    Bennett JP
    J Neurol Sci; 1999 Nov; 170(2):75-6. PubMed ID: 10561521
    [No Abstract]   [Full Text] [Related]  

  • 17. Neuroprotective therapy for Parkinson's disease.
    Koller WC
    Exp Neurol; 1997 Mar; 144(1):24-8. PubMed ID: 9126147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of endoplasmic reticulum stress in Parkinson's disease.
    Tsujii S; Ishisaka M; Hara H
    Eur J Pharmacol; 2015 Oct; 765():154-6. PubMed ID: 26297973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Selegiline in Parkinson's disease; symptomatic or causal effect?].
    Wolters EC; Kuiper MA; Horstink MW
    Ned Tijdschr Geneeskd; 1992 Aug; 136(32):1544-7. PubMed ID: 1528279
    [No Abstract]   [Full Text] [Related]  

  • 20. [Arguments in favor of the early treatment of Parkinson's disease with L-Dopa].
    Broussolle E
    Rev Neurol (Paris); 1999 Jan; 155(1):27-33. PubMed ID: 10093845
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.